Anxiety Pill That Isn’t Xanax: Evidence on Non-Benzo Options

By HealthDataConsortium.org Research Team. Sources opened and checked October 3, 2026. HealthDataConsortium.org is an independent analytical publication. This article has not been clinically or peer reviewed, and its contributors are researchers, not licensed healthcare practitioners. It is general information, not medical advice. Do not start, stop, or change any medicine because of what you read here. It does not recommend, rate, or sell any product, and it contains no affiliate links.

Short answer: There is no single “magic” anxiety pill that replaces Xanax. Xanax (alprazolam) is a benzodiazepine, a fast-acting class of medicine (Managed Healthcare Executive). The main prescription alternatives are antidepressants such as SSRIs and SNRIs, a medicine called buspirone, and, for short-term physical symptoms, beta-blockers prescribed off-label. Talk therapy is also a standard option. Most of these work more slowly than a benzodiazepine, and each has its own risks. Which one fits depends on the type of anxiety, your health history, and your other medicines, so the decision belongs in a conversation with a prescriber.

Why people look for a Xanax alternative

Anxiety disorders are common. The National Institute of Mental Health (NIMH) says about a third of U.S. adolescents and adults experience one at some point in their lives (NIMH, Anxiety Disorders).

Benzodiazepines carry a serious safety warning. In September 2020 the FDA required the Boxed Warning, its most prominent warning, to be updated for all benzodiazepines. The FDA says that even at recommended doses these medicines can lead to misuse, abuse, and addiction. It says abuse and misuse can result in overdose or death, especially when combined with opioid pain relievers, alcohol, or illicit drugs. It also says physical dependence can occur when they are taken steadily for several days to weeks, even as prescribed, and that stopping abruptly or lowering the dose too fast can cause withdrawal reactions, including seizures that can be life-threatening (FDA Drug Safety Podcast).

That does not make benzodiazepines the wrong choice for everyone. NIMH says they can be very effective at rapidly decreasing anxiety, and that providers usually prescribe them for short periods and taper them slowly (NIMH, Mental Health Medications). It does explain why many people ask what else exists.

Comparison: non-benzodiazepine options at a glance

This is a list, not a ranking. Where our sources did not give a fact, we say so instead of filling the gap. None of the sources we used compares these options head to head.

SSRIs and SNRIs (antidepressants also used for anxiety)

• Typical onset: NIMH says antidepressants usually take 4 to 8 weeks to work (NIMH).
• What the source says about evidence: NIMH says these medicines are commonly prescribed because they improve symptoms of a broad group of depressive and anxiety disorders. For panic disorder or social anxiety disorder, providers typically start with SSRIs or other antidepressants because they have fewer side effects than other medications.
• Common side effects: NIMH lists upset stomach, headache, and sexual dysfunction, which are generally mild and tend to go away with time. For generalized anxiety disorder it also lists nausea and trouble sleeping, and says side effects are usually not severe when the dose starts low and increases slowly (NIMH, Generalized Anxiety Disorder).
• Dependence and stopping: Our sources do not give a dependence comparison. NIMH does say not to stop a prescribed medicine on your own, because stopping too soon may cause unpleasant or harmful side effects.
• Other cautions from NIMH: Children, teenagers, and young adults under 25 may have more suicidal thoughts or behavior on antidepressants, especially in the first few weeks or after a dose change. Mixing antidepressants with other serotonin-acting products, such as migraine triptans or the supplement St. John's wort, can cause a rare but life-threatening illness called serotonin syndrome.

Buspirone

• Typical onset: It must be taken every day for 3 to 4 weeks to reach full effect, and it does not work on an as-needed basis (NIMH).
• What the source says about evidence: NIMH says it can be helpful for generalized anxiety disorder. The page does not rate its strength against other options.
• Common side effects: The NIMH pages we used do not list them. Ask your pharmacist for the Medication Guide.
• Dependence risk: NIMH says buspirone is not a sedative and has less potential to be addictive than benzodiazepines (NIMH).

Beta-blockers such as propranolol (off-label)

• Typical onset: No onset time is given in our sources. NIMH describes beta-blockers as useful as needed to reduce short-term anxiety. It says providers may prescribe them off-label, meaning the FDA has not approved them for this purpose, and that they can help manage physical symptoms such as rapid heart rate, sweating, and tremors (NIMH).
• What the sources say about evidence: A Northeastern University story reports that some experts say the evidence for propranolol in anxiety is limited. The pharmacy professor quoted there said a physician's first choice for an anxiety disorder would not be propranolol, and that it is not FDA-approved for anxiety (Northeastern Global News, September 15, 2025).
• Common side effects: The same story names tiredness and nightmares as frequent side effects.
• Risks: According to that story, taking it daily without a high blood pressure diagnosis can lead to low blood pressure, and taking too much can cause cardiac failure. NIMH says beta-blockers are generally not recommended for people with asthma or diabetes because they may worsen both.
• Dependence risk: The Northeastern story calls it a non-controlled medication. Our sources do not discuss dependence further.

Hydroxyzine

• What it is: An antihistamine that Cleveland Clinic says may also be used to treat anxiety (Cleveland Clinic).
• Common side effects: Drowsiness, dry mouth, and headache. Cleveland Clinic says it may affect coordination, reaction time, and judgment, and that alcohol raises that risk. It says to report heart rhythm changes, such as a fast or irregular heartbeat, right away, and to tell your care team if you have heart disease or an irregular heartbeat.
• Onset, evidence strength, and dependence risk: We did not find a source we could verify for these, so we do not rate them. Ask your prescriber.

Talk therapy: CBT and ACT

• Typical onset: NIMH says therapy and medication can both take some time to work, and that finding the best treatment may take trial and error (NIMH).
• What the source says about evidence: NIMH calls cognitive behavioral therapy (CBT) a research-supported treatment, well studied, and the “gold standard” choice for psychotherapy. It says a growing body of research supports acceptance and commitment therapy (ACT) for generalized anxiety disorder.
• Access: NIMH says therapy can be effective in person or by telehealth.
• Dependence risk: Not applicable, because therapy is not a medicine.

For reference: benzodiazepines such as Xanax

• Typical onset: NIMH says they can be very effective at rapidly decreasing anxiety.
• Dependence risk: See the FDA Boxed Warning described above. NIMH says some people build tolerance and need higher doses, and that some become dependent.

Why there is no “magic pill”

The Northeastern story quotes a pharmaceutical sciences professor who says most anxiety drugs have sedative effects. He calls a drug that relieves anxiety without causing sleepiness one of the “holy grails” of anxiety research. He also says no new anxiety medication had reached the market in the previous 20 years as of that story.

Limits of this comparison

• NIMH says its medication page is not a complete source and should not be used as a guide for medical decisions. Other medicines are sometimes used for anxiety, and this article does not cover them.
• We did not find head-to-head trial numbers in the sources we opened, so we do not say one option beats another.
• People respond differently. NIMH says it may take several tries to find the medicine that works best with the fewest side effects.
• Prescribing information changes. The FDA benzodiazepine page we cite is dated 2020 and shows content current as of January 2022. Ask your prescriber or pharmacist what is current.

Supplements, CBD, and your medicine list

If you take CBD, St. John's wort, or any other supplement, tell your prescriber and pharmacist. As noted above, NIMH warns that St. John's wort can combine dangerously with antidepressants. Our guide to CBD and liver test results: questions to take to your prescriber or pharmacist shows one way to organize a product, a medicine list, and your questions for that conversation.

Who should seek professional advice

• Anyone whose anxiety causes problems in everyday life, such as at work, at school, or in relationships. NIMH says that is the time to seek professional help.
• Anyone taking a benzodiazepine who wants to switch or stop. Do not stop suddenly. The FDA warns that abrupt stopping can cause serious withdrawal reactions, including seizures.
• Anyone with asthma, diabetes, heart disease, or an irregular heartbeat. Tell the prescriber, because some cautions named above relate to these conditions.
• Anyone under 25 starting an antidepressant, and the people supporting them, because of the NIMH warning about the early weeks.
• If you or someone you know is struggling or having thoughts of suicide, call or text 988, the 988 Suicide and Crisis Lifeline. In a life-threatening situation, call 911.

Questions to bring to a prescriber visit

1. What type of anxiety do you think I have, and how did you decide that?
2. Which options fit my situation: daily medicine, as-needed medicine, therapy, or a combination?
3. How long will each option take to work, and what should I expect in the first few weeks?
4. What side effects are most common, and which should I report right away?
5. Does anything on my medicine and supplement list, or any other condition I have, change your advice?
6. If I am on a benzodiazepine now, what would a safe, gradual plan look like?
7. What is the plan if the first option does not work, and when should we check in?

What to do next

1. Write down your symptoms, when they started, and how they affect your days.
2. List every medicine and supplement you take, with doses.
3. Book a visit with a primary care provider, psychiatrist, psychologist, or clinical social worker. NIMH says a primary care provider can refer you to a mental health professional.
4. Bring the question list above.

Sources

All pages below were opened October 3, 2026.

1. National Institute of Mental Health, “Mental Health Medications” (last reviewed December 2023)
2. National Institute of Mental Health, “Generalized Anxiety Disorder: What You Need to Know” (revised 2025)
3. National Institute of Mental Health, “Anxiety Disorders” (last reviewed December 2024)
4. U.S. Food and Drug Administration, “FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class” (September 23, 2020 requirement; content current as of January 14, 2022)
5. Northeastern Global News, “Celebrities use this common heart medication to calm anxiety. Should you try propranolol?” (September 15, 2025)
6. Cleveland Clinic, “Hydroxyzine Solution: Uses and Side Effects”
7. Managed Healthcare Executive, “FDA requires new boxed warning on benzodiazepines” (September 29, 2020)

This article is for informational purposes only and is not medical advice. Talk to a qualified healthcare professional about your symptoms, medicines, and treatment options.